Propyl 2-[(2-aminoacetyl)amino]acetate;hydrochloride | 13054-14-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Propyl 2-[(2-aminoacetyl)amino]acetate;hydrochloride
• 英文别名: propyl 2-[(2-aminoacetyl)amino]acetate;hydrochloride
• CAS: 13054-14-3
• 化学式: C₇H₁₄N₂O₃*ClH
• 分子量: 210.661
• InChiKey: MANRZSSNMAZRNU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.56
• 重原子数：
  13
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  81.4
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 Propyl 2-[(2-aminoacetyl)amino]acetate;hydrochloride 、 烯啶虫胺 在 三乙胺 作用下， 以 乙醇 为溶剂， 反应 0.42h， 以75.8%的产率得到N-(propoxycarbonylmethyl)-2-[4-[(6-chloro-3-pyridinylmethyl)ethylamino]-3-methyl-5-nitro-1-(1,2,3,6-tetrahydropyrimidinyl)]acetamide
  参考文献：
  名称：

  of的设计，合成，杀虫鉴定和分子对接研究。 顺式-nitenpyram类似物，带有二甘氨酸酯

  摘要：

  基于受体结构指导的新烟碱设计策略，设计并合成了一系列带有二甘氨酸酯的新型顺式-硝苯并吡喃类似物。初步的生物分析表明，与我们以前的工作相比，目标化合物的杀虫谱得到了扩展，而所有目标化合物在100 mg / L的浓度下均对Lupas lugens和Aphis medicagini表现出优异的杀虫活性。在这些类似物中，6b的抗褐飞虱死亡率为100％（LC 50 = 0.163 mg / L），抗药性的蚜虫为90％（4 mg / L）。特区建议，我们设计的顺式的杀虫效力-nitenpyram类似物受酯基团的大小和种类双重控制。分子对接模拟显示，与先前设计的化合物相比，这些类似物的结构独特性可能导致独特的分子识别和结合模式。肽键的引入在与昆虫nAChRs的氨基酸残基键合的乙炔吡喃类似物之间产生了更重要的氢键。对接结果解释了在体外观察到的SAR ，并阐明了这些顺式-硝苯并吡喃类似物的新型杀虫机理。

  DOI：

  10.1007/s11426-012-4748-x

文献信息

• PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN
  申请人：SHISEIDO COMPANY LIMITED

  公开号：EP1688126A1

  公开（公告）日：2006-08-09

  To provide a parakeratosis inhibitor, pore reducing agent and skin roughness preventing/ameliorating agent that exhibit capabilities of parakeratosis inhibition, pore reduction, skin roughness prevention/amelioration, etc., and further provide a skin preparation for external use having these capabilities. There are provide a parakeratosis inhibitor and a pore reducing agent each comprising at least one compound selected from the group consisting of a glycine derivative, an aminodicarboxylic acid derivative, an acylaminodicarboxylic acid derivative, a pyrrolidinecarboxylic acid derivative, a piperidinecarboxylic acid derivative, a hexamethyleneiminecarboxylic acid, a beta-alanine derivative and salts of these derivatives. Further, there are provided a parakeratosis inhibitor, a pore reducing agent and a skin roughness preventing/ameliorating agent each comprising at least one compound selected from the group consisting of specified glycine derivatives and salts thereof and specified aminosulfuric acid derivatives and salts thereof. Still further, there are provided skin preparations for external use comprising these compounds.

  提供一种具有抑制角化病、缩小毛孔、防止/改善皮肤粗糙等功能的角化病抑制剂、毛孔缩小剂和皮肤粗糙防止/改善剂，并进一步提供一种具有这些功能的外用皮肤制剂。本发明提供了一种角化抑制剂和一种毛孔缩小剂，它们都包含至少一种选自以下组别的化合物：甘氨酸衍生物、氨基二羧酸衍生物、酰氨基二羧酸衍生物、吡咯烷羧酸衍生物、哌啶羧酸衍生物、六亚甲基亚氨基羧酸、β-丙氨酸衍生物和这些衍生物的盐。此外，还提供了一种角化抑制剂、一种毛孔缩小剂和一种防止/改善皮肤粗糙剂，每一种都包含至少一种选自特定甘氨酸衍生物及其盐类和特定氨基硫酸衍生物及其盐类的化合物。此外，还提供了包含这些化合物的外用皮肤制剂。
• Parakeratosis inhibitor and skin preparation for external use
  申请人：SHISEIDO COMPANY LIMITED

  公开号：EP2491980A2

  公开（公告）日：2012-08-29

  To provide a parakeratosis inhibitor agent or a pore-shrinking agent comprising one or two or more compounds selected from a group consisting of benzoylaminodicarboxylic acid derivatives or benzenesulfonylaminodicarboxylic acid derivatives, as well as the salts of said derivatives as represented by general formula (2) (2) and a skin preparation for inhibiting parakeratosis for external use comprising a parakeratosis inhibitor agent and a skin preparation for shrinking pores for external use comprising a pore-shrinking agent.

  提供一种角化病抑制剂或毛孔收缩剂，其包含一种或两种或两种以上选自苯甲酰氨基二羧酸衍生物或苯磺酰氨基二羧酸衍生物以及通式(2)代表的上述衍生物的盐类的化合物。 (2) 和一种抑制角化病的外用皮肤制剂，包括一种角化病抑制剂和一种收缩毛孔的外用皮肤制剂，包括一种收缩毛孔剂。
• Parakeratosis inhibitor and external composition for skin
  申请人：SHISEIDO COMPANY LIMITED

  公开号：EP2491981A2

  公开（公告）日：2012-08-29

  To provide a parakeratosis inhibitor agent, pore-shrinking agent, or skin roughness preventing/ameliorating agent comprising one or two or more compounds selected from a group consisting of aminosulfuric acid derivatives and the salts thereof as represented by general formula (10) (10), a skin preparation for inhibiting parakeratosis for external use comprising a parakeratosis inhibitor agent, a skin preparation for shrinking pores for external use comprising a pore-shrinking agent and a skin preparation for preventing/ameliorating skin roughness for external use comprising a skin roughness preventing/ameliorating agent.

  提供一种角化抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂，其包含一种或两种或两种以上选自氨基硫酸衍生物及其盐组成的组的化合物，如通式（10）所示 (10)，一种外用的抑制角化病的皮肤制剂，包括角化病抑制剂；一种外用的收缩毛孔的皮肤制剂，包括毛孔收缩剂；一种外用的防止/改善皮肤粗糙的皮肤制剂，包括防止/改善皮肤粗糙剂。
• Parakeratosis Inhibitor and Skin Preparation for External use
  申请人：Kaminuma Mikiko

  公开号：US20070225380A1

  公开（公告）日：2007-09-27

  To provide a parakeratosis inhibitor, pore reducing agent and skin roughness preventing/ameliorating agent that exhibit capabilities of parakeratosis inhibition, pore reduction, skin roughness prevention/amelioration, etc., and further provide a skin preparation for external use having these capabilities. There are provide a parakeratosis inhibitor and a pore reducing agent each comprising at least one compound selected from the group consisting of a glycine derivative, an aminodicarboxylic acid derivative, an acylaminodicarboxylic acid derivative, a pyrrolidinecarboxylic acid derivative, a piperidinecarboxylic acid derivative, a hexamethyleneiminecarboxylic acid, a beta-alanine derivative and salts of these derivatives. Further, there are provided a parakeratosis inhibitor, a pore reducing agent and a skin roughness preventing/ameliorating agent each comprising at least one compound selected from the group consisting of specified glycine derivatives and salts thereof and specified aminosulfuric acid derivatives and salts thereof. Still further, there are provided skin preparations for external use comprising these compounds.
• PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE
  申请人：Kaminuma Mikiko

  公开号：US20120053243A1

  公开（公告）日：2012-03-01

  To provide a parakeratosis inhibitor, pore reducing agent and skin roughness preventing/ameliorating agent that exhibit capabilities of parakeratosis inhibition, pore reduction, skin roughness prevention/amelioration, etc., and further provide a skin preparation for external use having these capabilities. There are provide a parakeratosis inhibitor and a pore reducing agent each comprising at least one compound selected from the group consisting of a glycine derivative, an aminodicarboxylic acid derivative, an acylaminodicarboxylic acid derivative, a pyrrolidinecarboxylic acid derivative, a piperidinecarboxylic acid derivative, a hexamethyleneiminecarboxylic acid, a beta-alanine derivative and salts of these derivatives. Further, there are provided a parakeratosis inhibitor, a pore reducing agent and a skin roughness preventing/ameliorating agent each comprising at least one compound selected from the group consisting of specified glycine derivatives and salts thereof and specified aminosulfuric acid derivatives and salts thereof. Still further, there are provided skin preparations for external use comprising these compounds.